Evolent Health, Inc. Revenue
Evolent Health, Inc. (EVH) reported Revenue of $652.52 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $652.52M, a 46.86% increase year-over-year.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $496.25M, a 2.60% increase year-over-year.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $468.72M, a 27.50% decline year-over-year.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $479.53M, a 22.83% decline year-over-year.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.88B, a 26.56% decline from fiscal 2024.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $2.55B, a 30.09% increase from fiscal 2023.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.96B, a 45.26% increase from fiscal 2022.
- Evolent Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.35B, a 48.91% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $652.52M 10-Q · filed 2026-08-06 | $1.15B 10-Q · filed 2026-08-06 | $1.62B derived: sum of 3 quarters · filed 2026-08-06 | $2.10B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $496.25M 10-Q · filed 2026-05-07 | $964.97M derived: sum of 2 quarters · filed 2026-05-07 | $1.44B derived: sum of 3 quarters · filed 2026-05-07 | $1.89B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $468.72M 10-K · filed 2026-02-25 | $948.25M derived: sum of 2 quarters · filed 2026-02-25 | $1.39B derived: sum of 3 quarters · filed 2026-08-06 | $1.88B 10-K · filed 2026-02-25 | |
| 2025-09-30 | $479.53M 10-K · filed 2026-02-25 | $923.86M derived: sum of 2 quarters · filed 2026-08-06 | $1.41B 10-Q · filed 2025-11-07 | $2.05B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $444.33M 10-Q · filed 2026-08-06 | $927.98M 10-Q · filed 2026-08-06 | $1.57B derived: sum of 3 quarters · filed 2026-08-06 | $2.20B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $483.65M 10-Q · filed 2026-05-07 | $1.13B derived: sum of 2 quarters · filed 2026-05-07 | $1.75B derived: sum of 3 quarters · filed 2026-05-07 | $2.40B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $646.54M 10-K · filed 2026-02-25 | $1.27B derived: sum of 2 quarters · filed 2026-02-25 | $1.92B derived: sum of 3 quarters · filed 2026-02-25 | $2.55B 10-K · filed 2026-02-25 | |
| 2024-09-30 | $621.40M 10-K · filed 2026-02-25 | $1.27B derived: sum of 2 quarters · filed 2026-02-25 | $1.91B 10-Q · filed 2025-11-07 | $2.46B derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $647.14M 10-K · filed 2026-02-25 | $1.29B 10-Q · filed 2025-08-11 | $1.84B derived: sum of 3 quarters · filed 2026-02-25 | $2.35B derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $639.65M 10-K · filed 2026-02-25 | $1.20B derived: sum of 2 quarters · filed 2026-02-25 | $1.71B derived: sum of 3 quarters · filed 2026-02-25 | $2.18B derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $556.05M 10-K · filed 2025-02-21 | $1.07B derived: sum of 2 quarters · filed 2025-02-21 | $1.54B derived: sum of 3 quarters · filed 2025-02-21 | $1.96B 10-K · filed 2026-02-25 | |
| 2023-09-30 | $511.01M 10-K · filed 2025-02-21 | $980.15M derived: sum of 2 quarters · filed 2025-02-21 | $1.41B 10-Q · filed 2024-11-08 | $1.79B derived: sum of 4 quarters · filed 2025-02-21 | |
| 2023-06-30 | $469.14M 10-K · filed 2025-02-21 | $896.83M 10-Q · filed 2024-08-09 | $1.28B derived: sum of 3 quarters · filed 2025-02-21 | $1.63B derived: sum of 4 quarters · filed 2025-02-21 | |
| 2023-03-31 | $427.69M 10-K · filed 2025-02-21 | $810.12M derived: sum of 2 quarters · filed 2025-02-21 | $1.16B derived: sum of 3 quarters · filed 2025-02-21 | $1.48B derived: sum of 4 quarters · filed 2025-02-21 | |
| 2022-12-31 | $382.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $735.02M derived: sum of 2 quarters · filed 2025-02-21 | $1.05B derived: sum of 3 quarters · filed 2025-02-21 | $1.35B 10-K · filed 2025-02-21 | |
| 2022-09-30 | $352.58M 10-Q · filed 2023-11-02 | $672.52M derived: sum of 2 quarters · filed 2023-11-02 | $969.58M 10-Q · filed 2023-11-02 | $1.22B derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-06-30 | $319.94M 10-Q · filed 2023-08-03 | $617.00M 10-Q · filed 2023-08-03 | $865.35M derived: sum of 3 quarters · filed 2024-02-23 | $1.09B derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-03-31 | $297.06M 10-Q · filed 2023-05-04 | $545.41M derived: sum of 2 quarters · filed 2024-02-23 | $767.89M derived: sum of 3 quarters · filed 2024-02-23 | $989.94M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2021-12-31 | $248.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $470.83M derived: sum of 2 quarters · filed 2024-02-23 | $692.89M derived: sum of 3 quarters · filed 2024-02-23 | $907.96M 10-K · filed 2024-02-23 | |
| 2021-09-30 | $222.47M 10-Q · filed 2022-11-03 | $444.53M derived: sum of 2 quarters · filed 2022-11-03 | $659.60M 10-Q · filed 2022-11-03 | $931.52M derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $222.06M 10-Q · filed 2022-08-03 | $437.13M 10-Q · filed 2022-08-03 | $709.05M derived: sum of 3 quarters · filed 2022-08-03 | $973.64M derived: sum of 4 quarters · filed 2022-08-03 | |
| 2021-03-31 | $215.07M 10-Q · filed 2022-05-05 | $486.99M derived: sum of 2 quarters · filed 2022-05-05 | $751.59M derived: sum of 3 quarters · filed 2022-05-05 | $990.22M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $271.92M 10-K · filed 2021-02-26 | $536.52M derived: sum of 2 quarters · filed 2021-02-26 | $775.15M derived: sum of 3 quarters · filed 2021-02-26 | $924.64M 10-K · filed 2023-02-24 | $1.02B 10-K · filed 2021-02-26 |
| 2020-09-30 | $264.59M 10-K · filed 2021-02-26 | $503.23M derived: sum of 2 quarters · filed 2021-02-26 | $750.51M 10-Q · filed 2020-11-06 | $987.03M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2020-06-30 | $238.63M 10-K · filed 2021-02-26 | $485.92M 10-Q · filed 2020-08-07 | $722.44M derived: sum of 3 quarters · filed 2021-02-26 | $942.59M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2020-03-31 | $247.28M 10-K · filed 2021-02-26 | $483.81M derived: sum of 2 quarters · filed 2021-02-26 | $703.95M derived: sum of 3 quarters · filed 2021-02-26 | $895.91M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-12-31 | $236.53M 10-K · filed 2021-02-26 | $456.67M derived: sum of 2 quarters · filed 2021-02-26 | $648.63M derived: sum of 3 quarters · filed 2021-02-26 | $846.38M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $220.14M 10-K · filed 2021-02-26 | $412.10M derived: sum of 2 quarters · filed 2021-02-26 | $609.86M 10-Q · filed 2020-11-06 | $802.96M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $191.96M 10-K · filed 2021-02-26 | $389.71M 10-Q · filed 2020-08-07 | $582.82M derived: sum of 3 quarters · filed 2021-02-26 | $732.77M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $197.76M 10-K · filed 2021-02-26 | $390.86M derived: sum of 2 quarters · filed 2021-02-26 | $540.81M derived: sum of 3 quarters · filed 2021-02-26 | $685.11M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $193.10M 10-K · filed 2020-03-02 | $343.05M derived: sum of 2 quarters · filed 2020-03-02 | $487.35M derived: sum of 3 quarters · filed 2020-03-02 | $627.06M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $149.95M 10-K · filed 2020-03-02 | $294.25M derived: sum of 2 quarters · filed 2020-03-02 | $433.96M 10-Q · filed 2019-11-05 | $547.69M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $144.30M 10-K · filed 2020-03-02 | $284.01M 10-Q · filed 2019-08-09 | $397.74M derived: sum of 3 quarters · filed 2020-03-02 | $505.65M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $139.71M 10-K · filed 2020-03-02 | $253.44M derived: sum of 2 quarters · filed 2020-03-02 | $361.36M derived: sum of 3 quarters · filed 2020-03-02 | $468.43M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $113.73M 10-K · filed 2019-02-28 | $221.64M derived: sum of 2 quarters · filed 2019-02-28 | $328.71M derived: sum of 3 quarters · filed 2019-02-28 | $434.95M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $107.91M 10-K · filed 2019-02-28 | $214.98M derived: sum of 2 quarters · filed 2019-02-28 | $321.22M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $107.07M 10-K · filed 2019-02-28 | $213.31M 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $106.24M 10-K · filed 2019-02-28 | ||||
| 2016-12-31 | $254.19M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |